The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Curnutte John T since 2014.
The trader's CIK number is 1574589.
At the time of the last reporting, Curnutte John T was the Executive Vice President of Portola Pharmaceuticals Inc. (stock ticker symbol PTLA).
Also see all insider trading activities at Portola Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | PTLA | 0 | $0 | 0 | $0 | 40,049 | $42,916 |
| 2017 | PTLA | 0 | $0 | 70,000 | $4,121,000 | 91,000 | $757,750 |
| 2015 | PTLA | 0 | $0 | 90,000 | $3,706,900 | 90,000 | $765,000 |
| 2014 | PTLA | 0 | $0 | 40,000 | $1,109,970 | 40,000 | $340,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-08-31 | PTLA | Option Ex | 17,500 | .00 | 0 |
| 2018-07-28 | PTLA | Option Ex | 17,500 | .00 | 0 |
| 2018-03-12 | PTLA | Option Ex | 5,049 | 8.50 | 42,916 |
| 2017-09-28 | PTLA | Option Ex | 21,000 | 7.75 | 162,750 |
| 2017-07-18 | PTLA | Option Ex | 10,000 | 8.50 | 85,000 |
| 2017-07-18 | PTLA | Sale | 10,000 | 65.00 | 650,000 |
| 2017-06-26 | PTLA | Option Ex | 60,000 | 8.50 | 510,000 |
| 2017-06-26 | PTLA | Sale | 60,000 | 57.85 | 3,471,000 |
| 2015-07-15 | PTLA | Sale | 10,000 | 50.00 | 500,000 |
| 2015-07-15 | PTLA | Option Ex | 10,000 | 8.50 | 85,000 |
| 2015-06-22 | PTLA | Option Ex | 10,000 | 8.50 | 85,000 |
| 2015-06-22 | PTLA | Sale | 10,000 | 47.50 | 475,000 |
| 2015-06-16 | PTLA | Option Ex | 10,000 | 8.50 | 85,000 |
| 2015-06-16 | PTLA | Sale | 10,000 | 45.00 | 450,000 |
| 2015-05-29 | PTLA | Sale | 10,000 | 42.50 | 425,000 |
| 2015-05-29 | PTLA | Option Ex | 10,000 | 8.50 | 85,000 |
| 2015-05-28 | PTLA | Sale | 10,000 | 40.69 | 406,900 |
| 2015-05-28 | PTLA | Option Ex | 10,000 | 8.50 | 85,000 |
| 2015-02-23 | PTLA | Option Ex | 10,000 | 8.50 | 85,000 |
| 2015-02-23 | PTLA | Sale | 10,000 | 40.00 | 400,000 |
| 2015-02-18 | PTLA | Option Ex | 10,000 | 8.50 | 85,000 |
| 2015-02-18 | PTLA | Sale | 10,000 | 37.50 | 375,000 |
| 2015-02-17 | PTLA | Option Ex | 10,000 | 8.50 | 85,000 |
| 2015-02-17 | PTLA | Sale | 10,000 | 35.00 | 350,000 |
| 2015-02-13 | PTLA | Sale | 10,000 | 32.50 | 325,000 |
| 2015-02-13 | PTLA | Option Ex | 10,000 | 8.50 | 85,000 |
| 2014-06-17 | PTLA | Option Ex | 20,000 | 8.50 | 170,000 |
| 2014-06-18 | PTLA | Option Ex | 10,000 | 8.50 | 85,000 |
| 2014-06-17 | PTLA | Sale | 20,000 | 27.50 | 550,000 |
| 2014-06-18 | PTLA | Sale | 10,000 | 30.00 | 300,000 |
| 2014-06-16 | PTLA | Option Ex | 10,000 | 8.50 | 85,000 |
| 2014-06-16 | PTLA | Sale | 10,000 | 26.00 | 259,970 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Curnutte John T (Executive Vice President of Portola Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.